Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Breast Neoplasms 3Neoplasms 2Lung Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Liver Neoplasms 1Hepatitis 1Glioblastoma 1Gastrointestinal Neoplasms 1Fibrosis 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1

Interventions

Tenofovir 2Sorafenib 2Low-Level Light Therapy 2High-Energy Shock Waves 2sonidegib 1ruxolitinib 1navitoclax 1hepatitis B hyperimmune globulin 1bavituximab 1adefovir dipivoxil 1Viusid 1Vitamin E 1Restraint, Physical 1Physical Therapy Modalities 1Pentoxifylline 1Magnetic Resonance Spectroscopy 1Liver Transplantation 1Lamivudine 1Independent Medical Evaluation 1Gemcitabine 1Everolimus 1Erlotinib Hydrochloride 1Enkephalin, Methionine 1Dietary Supplements 1Clinical Trials as Topic 1Breath Tests 1Blood Specimen Collection 1Angptl4 protein, mouse 1Albumin-Bound Paclitaxel 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Fibrosis × bavituximab × Clear all
NCT01264705 2020-11-12

Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer

University of Texas Southwestern Medical Center

Phase 1/2 Completed
47 enrolled 10 charts
Gastrointestinal

Fibrosis, Gastrointestinal Neoplasms, Hepatitis, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡